
Inupadenant (CHEM136340)
| Record Information | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||
| Creation Date | 2026-04-15 16:31:33 UTC | ||||||||
| Update Date | 2026-08-22 05:02:42 UTC | ||||||||
| Accession Number | CHEM136340 | ||||||||
| Identification | |||||||||
| Common Name | Inupadenant | ||||||||
| Class | Small Molecule | ||||||||
| Description | Inupadenant is an organic compound with the chemical formula C25H26F2N8O4S2. Inupadenant belongs to the piperazines, a subclass of diazinanes within the organic compounds. With an average molecular weight of 604.65 g/mol, Inupadenant is a heavy molecule. In terms of pharmacological activity, this organoheterocyclic compound acts as an antagonist of the Adenosine receptor A2a (ADORA2A). | ||||||||
| Contaminant Sources | Not Available | ||||||||
| Contaminant Type | Not Available | ||||||||
| Chemical Structure | |||||||||
| Synonyms | Not Available | ||||||||
| Chemical Formula | C25H26F2N8O4S2 | ||||||||
| Average Molecular Mass | 604.650 g/mol | ||||||||
| Monoisotopic Mass | 604.149 g/mol | ||||||||
| CAS Registry Number | 2246607-08-7 | ||||||||
| IUPAC Name | 7-amino-10-[2-[4-[2,4-difluoro-5-[2-[(S)-methylsulfinyl]ethoxy]phenyl]piperazin-1-yl]ethyl]-4-(furan-2-yl)-12-thia-3,5,6,8,10-pentazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7-tetraen-11-one | ||||||||
| Traditional Name | Not Available | ||||||||
| SMILES | C[S@+]([O-])CCOC1=CC(N2CCN(CCN3C(=O)SC4=C3N=C(N)N3N=C(N=C43)C3=CC=CO3)CC2)=C(F)C=C1F | ||||||||
| InChI Identifier | InChI=1S/C25H26F2N8O4S2/c1-41(37)12-11-39-19-14-17(15(26)13-16(19)27)33-7-4-32(5-8-33)6-9-34-22-20(40-25(34)36)23-29-21(18-3-2-10-38-18)31-35(23)24(28)30-22/h2-3,10,13-14H,4-9,11-12H2,1H3,(H2,28,30)/t41-/m0/s1 | ||||||||
| InChI Key | QYCCLUSYHJXDEX-RWYGWLOXSA-N | ||||||||
| Chemical Taxonomy | |||||||||
| Classification | Not classified | ||||||||
| Biological Properties | |||||||||
| Status | Detected and Not Quantified | ||||||||
| Origin | Not Available | ||||||||
| Cellular Locations | Not Available | ||||||||
| Biofluid Locations | Not Available | ||||||||
| Tissue Locations | Not Available | ||||||||
| Pathways | Not Available | ||||||||
| Applications | Not Available | ||||||||
| Biological Roles | Not Available | ||||||||
| Chemical Roles | Not Available | ||||||||
| Physical Properties | |||||||||
| State | Not Available | ||||||||
| Appearance | Not Available | ||||||||
| Experimental Properties |
| ||||||||
| Predicted Properties | Not Available | ||||||||
| Spectra | |||||||||
| Spectra |
| ||||||||
| Toxicity Profile | |||||||||
| Route of Exposure | Not Available | ||||||||
| Mechanism of Toxicity | Not Available | ||||||||
| Metabolism | Not Available | ||||||||
| Toxicity Values | Not Available | ||||||||
| Lethal Dose | Not Available | ||||||||
| Carcinogenicity (IARC Classification) | Not Available | ||||||||
| Uses/Sources | Not Available | ||||||||
| Minimum Risk Level | Not Available | ||||||||
| Health Effects | Not Available | ||||||||
| Symptoms | Not Available | ||||||||
| Treatment | Not Available | ||||||||
| Concentrations | |||||||||
| Not Available | |||||||||
| External Links | |||||||||
| Identifiers | Not Available | ||||||||
| References | |||||||||
| Synthesis Reference | Not Available | ||||||||
| MSDS | Not Available | ||||||||
| General References | Not Available | ||||||||